Stay updated on Trametinib and Pembrolizumab in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Trametinib and Pembrolizumab in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Trametinib and Pembrolizumab in NSCLC Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    Revision tag updated from v3.6.5 to v3.6.6. This indicates a newer version of the page has been published, with no visible changes to the study content.
    Difference
    0.1%
    Check dated 2026-08-31T17:49:14.000Z thumbnail image
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    Change Detected
    Summary
    The page revision label changed from v3.6.4 to v3.6.5, indicating an updated publication version. This reflects a minor update to the page metadata rather than changes to the trial details or user-facing content.
    Difference
    0.1%
    Check dated 2026-08-10T12:33:07.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    Revision v3.6.4 was added and Revision v3.6.3 was removed. This represents a minor update to the page's revision history.
    Difference
    0.1%
    Check dated 2026-07-27T06:35:10.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    Mid-July 2026 update timestamps were added to the study record and January 2026 timestamps were removed. This reflects a refresh of the record's revision history rather than changes to the study data.
    Difference
    0.2%
    Check dated 2026-07-20T01:33:11.000Z thumbnail image
  7. Check
    64 days ago
    Change Detected
    Summary
    Revision tag updated from v3.6.2 to v3.6.3 on the page footer, signaling an updated version of the page content.
    Difference
    0.1%
    Check dated 2026-07-05T12:26:33.000Z thumbnail image
  8. Check
    71 days ago
    Change Detected
    Summary
    Revision updated from v3.6.0 to v3.6.2 on the page, indicating a new build of the page. The change does not alter study data, eligibility criteria, or trial details.
    Difference
    0.1%
    Check dated 2026-06-28T09:12:43.000Z thumbnail image

Stay in the know with updates to Trametinib and Pembrolizumab in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Trametinib and Pembrolizumab in NSCLC Clinical Trial page.